What is a stock summary page? Click here for an overview.
Business Description
Inspire Medical Systems Inc
NAICS : 334510
SIC : 3845
ISIN : US4577301090
Description
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 14.01 | |||||
| Equity-to-Asset | 0.85 | |||||
| Debt-to-Equity | 0.05 | |||||
| Debt-to-EBITDA | 0.49 | |||||
| Interest Coverage | 1640.14 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 26.08 | |||||
| Beneish M-Score | -1.9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 45.3 | |||||
| 3-Year Book Growth Rate | 40.5 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 38.96 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 17.4 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 44.98 | |||||
| 9-Day RSI | 42.8 | |||||
| 14-Day RSI | 42.47 | |||||
| 3-1 Month Momentum % | 3.98 | |||||
| 6-1 Month Momentum % | -5.07 | |||||
| 12-1 Month Momentum % | -5.6 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 7.13 | |||||
| Quick Ratio | 6.22 | |||||
| Cash Ratio | 5.03 | |||||
| Days Inventory | 171.8 | |||||
| Days Sales Outstanding | 38.62 | |||||
| Days Payable | 112.7 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -2.7 | |||||
| Shareholder Yield % | 1.42 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 84.68 | |||||
| Operating Margin % | 4.5 | |||||
| Net Margin % | 6.67 | |||||
| FCF Margin % | 11.35 | |||||
| ROE % | 8.4 | |||||
| ROA % | 7.24 | |||||
| ROIC % | 14.73 | |||||
| 3-Year ROIIC % | 32.1 | |||||
| ROC (Joel Greenblatt) % | 35.78 | |||||
| ROCE % | 8.81 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 94.33 | |||||
| Forward PE Ratio | 75.3 | |||||
| PE Ratio without NRI | 94.33 | |||||
| Price-to-Owner-Earnings | 454.57 | |||||
| PS Ratio | 6.16 | |||||
| PB Ratio | 7.04 | |||||
| Price-to-Tangible-Book | 7.04 | |||||
| Price-to-Free-Cash-Flow | 54.78 | |||||
| Price-to-Operating-Cash-Flow | 38.19 | |||||
| EV-to-EBIT | 76.87 | |||||
| EV-to-Forward-EBIT | 83.68 | |||||
| EV-to-EBITDA | 69.13 | |||||
| EV-to-Forward-EBITDA | 71.34 | |||||
| EV-to-Revenue | 5.6 | |||||
| EV-to-Forward-Revenue | 4.73 | |||||
| EV-to-FCF | 49.33 | |||||
| Price-to-GF-Value | 0.45 | |||||
| Price-to-Projected-FCF | 10.05 | |||||
| Price-to-Graham-Number | 5.43 | |||||
| Price-to-Net-Current-Asset-Value | 9.48 | |||||
| Price-to-Net-Cash | 14.85 | |||||
| Earnings Yield (Greenblatt) % | 1.3 | |||||
| FCF Yield % | 1.88 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:INSP
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Inspire Medical Systems Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 802.804 | ||
| EPS (TTM) ($) | 1.73 | ||
| Beta | 0.91 | ||
| 3-Year Sharpe Ratio | 0.03 | ||
| 3-Year Sortino Ratio | 0.04 | ||
| Volatility % | 58.52 | ||
| 14-Day RSI | 42.47 | ||
| 14-Day ATR ($) | 8.129787 | ||
| 20-Day SMA ($) | 172.763 | ||
| 12-1 Month Momentum % | -5.6 | ||
| 52-Week Range ($) | 123 - 257.4 | ||
| Shares Outstanding (Mil) | 29.76 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Inspire Medical Systems Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Inspire Medical Systems Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Inspire Medical Systems Inc Frequently Asked Questions
What is Inspire Medical Systems Inc(INSP)'s stock price today?
The current price of INSP is $163.19. The 52 week high of INSP is $257.40 and 52 week low is $123.00.
When is next earnings date of Inspire Medical Systems Inc(INSP)?
The next earnings date of Inspire Medical Systems Inc(INSP) is 2025-05-07 Est..
Does Inspire Medical Systems Inc(INSP) pay dividends? If so, how much?
Inspire Medical Systems Inc(INSP) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers